JERSEY CITY, N.J. , July 21, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Autoinjector Contract Manufacturing Market By Product (Disposable Autoinjectors, Reusable Autoinjectors, Wearable Injector, and Smart/Connected Autoinjectors), Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, and Others), End-User (Homecare, Hospitals & Clinics, and Ambulatory Services))- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global autoinjector contract manufacturing market is valued at US$ 1.16 billion in 2021, and it is expected to reach US$ 2.80 billion by 2030, with a CAGR of 10.4% during the forecast period of 2022-2030.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1340
Autoinjector devices are helpful for the rapid administration of drugs and antidotes, and they can also be used by those who have not been medically trained. Hence, it makes them very convenient for emergency and mass casualty management. Autoinjectors are commonly used for self-administration of epinephrine (to prevent anaphylaxis), by migraine sufferers (for quick pain relief), and for medical and emergency treatments. Autoinjectors are widely gaining popularity among patients with conditions that necessitate many injections per day. One of the primary drivers of the Autoinjector Contract Manufacturing market is the growing number of patients who have rheumatoid arthritis, multiple sclerosis, diabetes, and growth hormone disorders. Autoinjectors are gaining popularity because they allow patients to inject their medication without hesitancy due to a fear of the needle-based drug delivery technique. Patient care and comfort are of the utmost importance to caregivers and patients alike; equipment such as Autoinjectors enables patients to administer their own doses without the need for medical expertise. Autoinjectors can be used anywhere without causing discomfort to the user or those around them. Autoinjectors lower the cost per injection for the user because the main body of the device does not need to be changed with each infusion.
Increase in R&D efforts by companies to design accessible, cost-effective, and innovative technology-based autoinjectors for the treatment of chronic conditions, as well as the rising demand for and manufacturing biologics, are weighing on the growth of the Autoinjector industry. Companies engaged in research and development are attempting to create innovative, cost-effective treatments for chronic diseases such as multiple sclerosis and rheumatoid arthritis. It is expected to expand the market's worth and reach very high levels in the coming years.
However, It is anticipated that the preference for other routes of medication administration, such as oral diabetes treatments and nasal epinephrine sprays, will reduce the use of Autoinjector devices. The development of needle-free medicine administration methods, such as jet injectors, also restrains market growth.
The North American region is projected to account for the most significant portion of the market for Autoinjector Contract Manufacturing. The region accounts for a sizable elderly population who rely on injections as part of their treatment for conditions including diabetes and rheumatoid arthritis. The region's significant insurance programmes have also aided in the market expansion for Autoinjector Contract Manufacturing. The vendors' technological innovations, particularly the creation of intelligent Autoinjectors, have contributed to the domination of the North American region.
Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1340
Major market players operating in the autoinjector contract manufacturing market include Phillips-Medisize (a Molex Company), Elcam Drug Delivery Devices (E3D) (Elcam Medical), Jabil Healthcare, Gerresheimer AG, Dali Medical Devices, Ypsomed Delivery Systems (YDS), SHL Medical, Haselmeier, Owen Mumford , Becton, Dickinson and Company (BD), CCBio, Nemera (Copernicus), Recipharm AB, Sonceboz, Solteam Medical, Stevanato Group, Union Medico ApS., Neuma Engineering, Emperra, Eitan Medical, Enable Injections, West Pharmaceutical Services, Inc., Delfu Medical, Wanhai Medical, and Other Prominent Player
Key developments in the market:
In June 2022 , Jabil Healthcare launched the Qfinity autoinjector platform, a reusable and modular solution for subcutaneous (S.C.) drug self-administration that intends to address the pharmaceutical industry's increasing priority of sustainable drug delivery. The Qfinity+ autoinjector, a linked version of the handheld device, enables medical teams to remotely monitor their patients' treatment and compliance thanks to integrated sensors and electronics.
In July 2022 , SHL Medical unveiled plans for a new production location in the U.S. in response to the expanding market demand for its autoinjector product range. The decision arises from SHL's strategic considerations in increasing its manufacturing in North America . In 2019, SHL created a long-term plan in response to the expanding autoinjector demand and to satisfy future production demands. The news of the new U.S. business corresponds with the company's continued development, including a new Swiss facility currently being revealed.
In May 2021 , Phillips-Medisize launched the Aria Smart Autoinjector platform to enable innovation, distinction and sustainability in the digital drug-delivery device industry. This newest breakthrough delivers a tiny and simple, smart injection device with a reusable electronic drive unit and single-use, disposable cassettes to boost patient care while lowering environmental impact.
In Mach 2020, SHL Medical recently announced the acquisition of Weibel CDS, a provider of new packaging and devices for drug administration in the field of medical technology.
Global Autoinjector Contract Manufacturing Market, by Product, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
Global Autoinjector Contract Manufacturing Market, by Application, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
Global Autoinjector Contract Manufacturing Market, by End-User, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
Global Autoinjector Contract Manufacturing Market, by Region, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
North America Autoinjector Contract Manufacturing Market, by Country, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
Europe Autoinjector Contract Manufacturing Market, by Country, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
Asia Pacific Autoinjector Contract Manufacturing Market, by Country, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
Latin America Autoinjector Contract Manufacturing Market, by Country, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
Middle East & Africa Autoinjector Contract Manufacturing Market, by Country, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
Rest of Middle East & Africa
For More Customization @ https://www.insightaceanalytic.com/customisation/1340
Why should buy this report:
To receive a comprehensive analysis of the manufacturing prospects for the global autoinjector market
To receive an industry overview and future trends of the autoinjector contract manufacturing market
To analyze the Autoinjector Contract Manufacturing market drivers and challenges
To get information on the Autoinjector Contract Manufacturing market size Value (US$ Mn) and Volume (No. of Units) forecast to 2030
To get information on major investments, mergers & acquisitions in the autoinjector contract manufacturing industry
Other Related Reports Published by InsightAce Analytic:
Global Pre-Fillable Syringe Closures and Accessories Market
Global Biosimilar/Generic Injectable Pens Market
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Us: InsightAce Analytic Pvt. Ltd. Tel.: +1 718 593 4405 Email: info@insightaceanalytic.com Site Visit: www.insightaceanalytic.com Follow Us on LinkedIn @ bit.ly/2tBXsgS Follow Us On Facebook @ bit.ly/2H9jnDZ
Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/autoinjector-contract-manufacturing-market-worth-2-80-billion-by-2030---exclusive-report-by-insightace-analytic-301590940.html
SOURCE InsightAce Analytic Pvt. Ltd.
Vascular Biogenics' (VBLT) phase III OVAL study, evaluating ofra-vec in patients with platinum-resistant ovarian cancer, fails to meet the primary endpoint.
Yahoo Finance's Pras Subramanian discusses the latest auto news from the Tesla-only lane at the U.S.-Mexico border to Volkswagen replacing its CEO.
We’re supposed to be energy independent. What gives?
One of Biden’s top energy aides confirmed Friday that no extension of releases from the Strategic Petroleum Reserve - scheduled to end this fall - is in the offing. But added a promise that it’s not going to lead to any supply shocks.
Tech giants Microsoft and Google have just taken additional hard decisions ahead of their earnings reports.
Fewer are reverting to traditional office jobs, with a growing number seeking nontraditional roles, or even the opportunity to start a new business.
Yahoo Finance's Josh Schafer breaks down the market debut for online media company FaZe Clan.
After Big Tech grew in unprecedented and unchecked fashion for a decade, building ostentatious palaces to house growing workforces while plying them luxuriant freebies to keep them from defecting to rivals, is the wild ride over?
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street pays close attention. The easiest way for investors to monitor what Warren Buffett has been buying and selling is to track Berkshire Hathaway's quarterly 13F filings with the Securities and Exchange Commission (SEC).
In June 2020, the Creating Helpful Incentives to Produce Semiconductors for America (CHIPS) Act was introduced in the House of Representatives by U.S. Rep. Michael McCaul (R-Texas). The act called for the U.S. to boost its subsidies for domestic chipmakers to address the global chip shortage, reduce the country's dependence on Asian chip foundries, and stay ahead of China in the semiconductor race. The CHIPS Act would provide $52 billion in subsidies and tax breaks for domestic chipmakers.
Danaher designs, manufactures and markets professional, medical, industrial, and commercial products and services. DHR posted an earnings beat Thursday and the price gapped higher. Let's check out the charts.
As a potential recession looms, investors should be prepared for the cloud boom to return to earth, and there is potential for a larger pullback in cloud spending that could have a domino effect on already bludgeoned tech stocks
Ford Motor Co (NYSE: F) is planning to slash as many as 8,000 jobs to boost investment into electric vehicle manufacturing, Bloomberg reported. The job loss is likely to happen in Ford's recently formed Ford Blue unit, which is in charge of internal combustion engine vehicle production and other operations. In March, the company created electric vehicle and internal combustion businesses, Model e and Ford Blue, respectively, to compete and win against both new EV competitors and established auto
(Bloomberg) -- Semiconductor Manufacturing International Corp. has likely advanced its production technology by two generations, defying US sanctions intended to halt the rise of China’s largest chipmaker.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Internal Tesla Purchasing ProbeStocks End Thre
U.S. steel companies are ramping up investments in new mills and side businesses, brushing aside signs of weakness in the broader economy as executives cited strengthening demand from customers in the auto and construction sectors. Major steel companies this week turned in quarterly results that were mostly better than expected, after steel prices rose sharply in spring because of the war in Ukraine. While prices have retreated in recent weeks, steel executives said demand isn’t deteriorating.
(Bloomberg) -- Volkswagen AG abruptly ousted Herbert Diess, its chief executive officer and architect of the auto industry’s biggest electrification effort, after repeated clashes with labor unions chipped away at his support with key stakeholders.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Int
Crypto exchange Coinbase has pushed against the U.S. Securities and Exchange Commission's claims that seven cryptocurrencies listed on the exchange were securities, while Flexa, issuer of one of the coins involved, said they have not been contacted by the agency.
Pilot Company CEO Shameek Konar joins Yahoo Finance Live to discuss its plans to roll out an EV charging network in partnership with GM and EVgo, and the outlook for the gas station and rest stop chain.
Yahoo Finance's Pras Subramanian, Dave Briggs, and Seana Smith discuss Tesla's earnings and market shares, Baidu's new vehicle, and the EV market.
Oil service giants are announcing second-quarter earnings this week, giving investors an idea of the outlook for oil production.